BECN1 and gastric cancer: Notably, the expression level of Beclin-1 in the LBP group was similar to that in normal AGS cells without special treatment, suggesting that the high expression of Beclin-1 in gastric cancer cells does not seem to be beneficial for antitumor therapy.